-
-
-
-
-
-
-
Summit Therapeutics (SMMT) Reiterated at Market Outperform by Citizens
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
-
-
-
-
-
-
-
Summit Therapeutics (SMMT) Tops Q3 EPS by 2c
-
-
-
-
-
-
-
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024
-
-
-
-
-
-
-
Summit Therapeutics to Host Fourth Quarter & Full Year 2023 Financial Results & Operational Progress Call on February 20, 2024
-
-
-
-
-
-
-
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023
-
1,198,724 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

